Deferoxamine Does Not Increase the Risk for Bacteremia in Hemodialysis Patients | Zendy

Christian Tielemans | Zendy; Johan R. Boelaert | Zendy; Philippe Vergauwe | Zendy; G. van Roost | Zendy; M. Segaert | Zendy; B. van Frachen | Zendy; Christine Lenclud | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Deferoxamine Does Not Increase the Risk for Bacteremia in Hemodialysis Patients

Author(s) -

Christian Tielemans,

Johan R. Boelaert,

Philippe Vergauwe,

G. van Roost,

M. Segaert,

B. van Frachen,

Christine Lenclud

Publication year - 1989

Publication title -

the nephron journals/nephron journals

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.951

H-Index - 72

eISSN - 2235-3186

pISSN - 1660-8151

DOI - 10.1159/000185758

Subject(s) - medicine , hemodialysis , bacteremia , deferoxamine , intensive care medicine , nephrology , gastroenterology , antibiotics , microbiology and biotechnology , biology

Deferoxamine Does Not Increase the Risk for Bacteremia in Hemodialysis Patients C. Tielemans J. Boelaert P. Vergauwe G. van Roost M. Segaert B. van Frachen C. Lenclud Department of Nephrology, Hôpital Universitaire Brugmann, Brussels;Units of Renal and Infectious Diseases, Algemeen Ziekenhuis St Jan, Bruges;Renal Unit, Heilig Hart Ziekenhuis, Roeselare;Renal Unit, Kliniek Sint Jan, Brussels, Belgium

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research